CBY1/PGEA1 抗体 (C-Term)
Quick Overview for CBY1/PGEA1 抗体 (C-Term) (ABIN653093)
抗原
See all CBY1/PGEA1 (CBY1) 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- AA 98-126, C-Term
-
纯化方法
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
免疫原
- This HRIHFB2025 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 98-126 amino acids from the C-terminal region of human HRIHFB2025.
-
亚型
- Ig Fraction
-
-
-
-
应用备注
- WB: 1:1000. IHC-P: 1:50~100. FC: 1:10~50
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
-
有效期
- 6 months
-
-
-
: "Identification of cisplatin-resistance related genes in head and neck squamous cell carcinoma." in: International journal of cancer. Journal international du cancer, Vol. 126, Issue 2, pp. 437-49, (2009) (PubMed).
-
: "Identification of cisplatin-resistance related genes in head and neck squamous cell carcinoma." in: International journal of cancer. Journal international du cancer, Vol. 126, Issue 2, pp. 437-49, (2009) (PubMed).
-
- CBY1/PGEA1 (CBY1) (Chibby Homolog 1 (CBY1))
-
别名
- HRIHFB2025
-
背景
- Inhibits the Wnt/Wingless pathway by binding to beta catenin and inhibiting beta catenin mediated transcriptional activation by competing with TCF/LEF transcription factors. Has also been shown to play a role in regulating the intracellular trafficking of polycystin 2/PKD2 and possibly of other intracellular proteins.
-
分子量
- 14470
-
基因ID
- 25776
-
NCBI登录号
- NP_001002880, NP_056188
-
UniProt
- Q9Y3M2
抗原
-